FindTrial
Sign In

The incidence of pulmonary embolism in patients undergoing abdominal flap breast reconstructions, a prospective study.

The incidence of pulmonary embolism in patients undergoing abdominal flap breast reconstructions, a prospective study. - Incidence of pulmonary embolism after abdominal flap breast reconstruction.

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41914
Enrollment
422
Registered
2015-10-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bloodclot in the lungs thrombus in the lungs

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients undergoing an abdominal flap breast reconstruction. Aged 18 years or older

Exclusion criteria

Exclusion criteria: Inability to confirm to the thrombosis prophylaxis protocol. Patients who are on anticoagulant medication or have coagulopathy.

Design outcomes

Primary

MeasureTime frame
The occurrence of a pulmonary embolism.—

Secondary

MeasureTime frame
To asses potential risk factors on pulmonary embolism: age, body mass index, BRCA1 and BRCA2 gene mutations, smoking, a history of cancer, presence of malignancy at the time of reconstruction, chemotherapy or hormonal therapy at the time of reconstruction, previous radiotherapy, timing of reconstruction (primary or secondary), laterality of reconstruction (unilateral or bilateral), operation duration, complication other than pulmonary embolism and number of re-operations will be recorded. To investigate the potential etiology of pulmonary embolism in patients undergoing an abdominal based breast reconstruction.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)